LigaChem Biosciences, Inc.
14 clinical trials · Sponsor
◉ Watch LigaChem Biosciences, Inc.
| Record | Firm | Date |
|---|---|---|
| A Study to Evaluate Claudin 18.2-Directed ADC LCB02A in Advanced Solid Tumors (NCT07460375) | LigaChem Biosciences, Inc. | 2026-08-01 |
| Study to Evaluate the Efficacy of Delpazolid as Add-on Therapy in Refractory Mycobacterium Abscessus Complex (NCT06004037) | LigaChem Biosciences, Inc. | 2024-01-16 |
| A Phase 2a Study, Effect of Vancomycin With vs Without Delpazolid (LCB01-0371) in Patients With MRSA Bacteremia (NCT05225558) | LigaChem Biosciences, Inc. | 2022-04-26 |
| PanACEA DElpazolid Dose-finding and COmbination DEvelopment (DECODE) (NCT04550832) | LigaChem Biosciences, Inc. | 2021-10-28 |
| Trial to Evaluate Bioequivalence of LCB01-0371 in Different Batches (NCT04939779) | LigaChem Biosciences, Inc. | 2021-01-14 |
| A Mass Balance Study of LCB01-0371 After a Single Oral LCB01-0371 Dose With a [14C]LCB01-0371-microtrace (NCT03492996) | LigaChem Biosciences, Inc. | 2020-06-21 |
Track LigaChem Biosciences, Inc. automatically
Every clearance here is in the API, with alerts when new ones post.